Treatment of breast cancer using a combination of a cationic liposomal formulation of taxane, a non-liposomal formulation of taxane and a further active agent

• 收藏
• 分享

专利权人:

Syncore Biotechnology Co., Ltd.; Ltd.;Syncore Biotechnology Co.;CanCap Pharmaceutical Ltd.

发明人:

Lin, Sih-Ting,Tseng, Hui-Yuan,Teng, Hsin-Wei

申请号：

AU2016383697

公开号：

AU2016383697A1

申请日:

2016.12.28

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present disclosure provides methods for the treatment of breast cancer, including triple negative breast cancer. Said methods comprise the administration of (a) a cationic liposomal formulation comprising a taxane, (b) a non-liposomal formulations comprising a taxane and (c) a further active agent. Said further active agent is preferably gemcitabine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/